Our Client strives to become a world leader in biologics CDMO. Providing first-class, large-scale biologics CDMO services to international biotech companies. Their clients can rely upon the most advanced equipment and process design, a world-class management team, and services tailored to client needs. The company has built a global management team with industry veterans, and other pharma giants. Working with global partners, the company is also building the first AI-Supported Smart Bio-Factory in Asia. Based on Digital 4.0 principles, are combining the power of IoT, augmented data analytics, and autonomous manufacturing systems, to revolutionize biologics CDMO services. Our Client is the first in China to utilize the 15kL bioreactor, driving production cost down significantly. In addition, the company is working with leading institution investors to establish VC funds of up to 10Bn RMB in total size, focusing on biomedicine projects.
Bioengineering, biotechnology and other related majors, with more than 8 years of work experience in undergraduate, and at least 5 years of experience in cell culture management
Highly experienced in upstream manufacturing in a GMP environment
Experience in the scale-up and tech transfer of biologics in the biopharmaceutical industry
Have a deep understanding of culture process, and be proficient in the process and operation of cell culture including, media preparation, vial thawing/expansion, bioreactors (pilot-scale disposable / stainless steel bioreactors), centrifugation, depth filtration, and related analytical instruments
Familiar with international GMP regulations and guidelines